BIOMEA FUSION (BMEA)
(Delayed Data from NSDQ)
$1.57 USD
-0.09 (-5.42%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.58 +0.01 (0.64%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Biomea Fusion, Inc. has a market cap of $62.37M, which represents its share price of $1.66 multiplied by its outstanding shares number of 37.57M. As a small-cap company, BMEA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BMEA 1.57 -0.09(-5.42%)
Will BMEA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BMEA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BMEA
Biomea Fusion (BMEA) Upgraded to Buy: Here's What You Should Know
After Plunging -27.9% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA)
BMEA: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging -19.32% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA)
After Plunging -20.42% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA)
BMEA Stock Up 9% as FDA Lifts Clinical Hold on 2 Diabetes Studies
Other News for BMEA
Biomea Fusion (BMEA) Welcomes New Board Member Julianne Averill | BMEA Stock News
Biomea Fusion Appoints Julianne Averill to its Board of Directors | BMEA Stock News
Biomea Fusion appoints Julianne Averill to board of directors
Biomea Fusion (BMEA) Maintains Buy Rating with Target Price of $16.00 | BMEA Stock News
Biomea Fusion (BMEA) Stock Update: Citigroup Lowers Price Target | BMEA Stock News